|
CCDC76 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.03312930327593E-13 |
| Normal-vs-Stage2 |
9.45959999221202E-09 |
| Normal-vs-Stage3 |
2.03170813506404E-14 |
| Normal-vs-Stage4 |
6.23210372197036E-11 |
| Stage1-vs-Stage2 |
5.065800E-01 |
| Stage1-vs-Stage3 |
1.232010E-02 |
| Stage1-vs-Stage4 |
1.315800E-02 |
| Stage2-vs-Stage3 |
2.841000E-01 |
| Stage2-vs-Stage4 |
1.857380E-01 |
| Stage3-vs-Stage4 |
5.869400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.4432899320127E-15 |
| Normal-vs-AfricanAmerican |
3.11279999998249E-06 |
| Normal-vs-Asian |
6.20520000049751E-07 |
| Caucasian-vs-AfricanAmerican |
9.800200E-01 |
| Caucasian-vs-Asian |
2.152600E-01 |
| AfricanAmerican-vs-Asian |
4.365400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.4776630160377E-13 |
| Normal-vs-Female |
1.62747593179802E-12 |
| Male-vs-Female |
5.304800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.96331839674713E-12 |
| Normal-vs-Age(41-60Yrs) |
1.80855330711438E-13 |
| Normal-vs-Age(61-80Yrs) |
3.07850411829236E-11 |
| Normal-vs-Age(81-100Yrs) |
1.415740E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.357420E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.627620E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.877200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.320800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.562000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.266800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.201500E-04 |
| Classical-VS-Follicular |
1.902000E-01 |
| Classical-VS-Other |
6.966400E-01 |
| Classical-VS-Normal |
1.63113966777928E-12 |
| Tall-VS-Follicular |
7.68549999999868E-05 |
| Tall-VS-Other |
3.590400E-02 |
| Tall-VS-Normal |
5.7065463465733E-14 |
| Follicular-VS-Other |
9.261200E-01 |
| Follicular-VS-Normal |
5.40479999977528E-07 |
| Other-VS-Normal |
1.537850E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.11701792049735E-13 |
| Normal-vs-N1 |
1.10649999995882E-06 |
| N0-vs-N1 |
6.517400E-01 |
|
|
